Recently, Hercules™ Balloon Inflation Catheter, independently developed by MicroPort and its subsidiary MicroPort Endovascular (Shanghai) Co., Ltd., received certificate from China Food and Drug Administration (CFDA). Hercules™ Balloon Inflation Catheter literary filled the gap in the domestic-made large balloon market and broke the dependence on the foreign-made products. The device effectively addresses the endoleak during the endovascular treatment for the aortic aneurysm or dissection.

An aneurysm or dissection occurs when a segment of the vessel becomes weakened. The pressure of the blood flowing through the vessel creates a bulge or tear at the weak spot, much as an overinflated inner tube can cause a bulge in a tire. The bulge or tear usually starts small and grows as the pressure continues. Aneurysms or dissections are dangerous because they can rupture, causing internal bleeding. Endovascular aneurysm repair (or endovascular aortic repair) (EVAR) is a type of endovascular surgery used to treat an aortic aneurysm (AAA) or dissection.

Hercules™ Balloon Inflation Catheter is mainly used for post-release stent expansion which allows the stent graft to fully fit the shape and contour of human blood vessels to prevent endoleak which is characterized by persistent blood flow within the aneurysm sac or false lumen following endovascular aneurysm repair (EVAR). This device used in combination with aortic stent graft offers a total solution for physicians and surgeons for treating aortic aneurysm or dissection.